213 related articles for article (PubMed ID: 25633200)
21. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
23. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
Tawfik AA; Alsharnoubi J
Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
[TBL] [Abstract][Full Text] [Related]
24. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
[TBL] [Abstract][Full Text] [Related]
25. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
[TBL] [Abstract][Full Text] [Related]
26. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
[TBL] [Abstract][Full Text] [Related]
27. A self-controlled study of intralesional injection of diprospan combined with topical timolol cream for treatment of thick superficial infantile hemangiomas.
Xu P; Yu Q; Huang H; Zhang W; Li W
Dermatol Ther; 2018 May; 31(3):e12595. PubMed ID: 29708630
[TBL] [Abstract][Full Text] [Related]
28. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.
Wu HW; Liu C; Wang X; Zhang L; Yuan W; Zheng JW; Su LX; Fan XD
Front Oncol; 2017; 7():137. PubMed ID: 28702374
[TBL] [Abstract][Full Text] [Related]
29. Topical timolol for an iris hemangioma.
Gummi R; Stahl ED; Marsh JD
J AAPOS; 2018 Apr; 22(2):156-158. PubMed ID: 29412149
[TBL] [Abstract][Full Text] [Related]
30. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
[TBL] [Abstract][Full Text] [Related]
31. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
[TBL] [Abstract][Full Text] [Related]
32. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
[TBL] [Abstract][Full Text] [Related]
33. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.
Anwar F; Mahmood E; Sharif S; Shah R; Jamgochian M; Ouellette S; Umar M; Rao B
J Drugs Dermatol; 2023 Jun; 22(6):594-598. PubMed ID: 37276157
[TBL] [Abstract][Full Text] [Related]
34. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
35. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
[TBL] [Abstract][Full Text] [Related]
36. [Usage and efficacy of timolol maleate eye drops in treatment of superficial infantile hemangioma].
Wu Q; Shi Q; Long J; Li J; Guo Y; Lei S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):657-661. PubMed ID: 28690223
[TBL] [Abstract][Full Text] [Related]
37. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
[TBL] [Abstract][Full Text] [Related]
38. Topical timolol for small infantile hemangioma: a new therapy option.
Weissenstein A; Straeter A; Villalon G; Bittmann S
Turk J Pediatr; 2012; 54(2):156-8. PubMed ID: 22734302
[TBL] [Abstract][Full Text] [Related]
39. Predictors of treatment responses of superficial infantile hemangiomas to topical timolol.
Zheng H; Cai Y; Xu Y; Yu Q; Kang B; Chen C; Gong X; Li W
Dermatol Ther; 2022 Nov; 35(11):e15833. PubMed ID: 36106484
[TBL] [Abstract][Full Text] [Related]
40. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Ge J; Zheng J; Zhang L; Yuan W; Zhao H
Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
